Studies have implicated that postmenopausal osteoporosis is partially mediated by the release of pro-inflammatory factors due to estrogen withdrawal, such as IL-6, TNF-α, and IL-1 (Mundy, 2007). The gene discussed is IL6; the disease is postmenopausal osteoporosis.